Mitochondrial VDAC1: Function in cell life and death and a target for cancer therapy

Current Medicinal Chemistry

Volumn 19, Issue 5, 2012, Pages 714-735

  Shoshan Barmatz, V ^a   Golan, M ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Apoptosis; Bcl2 family proteins; Cancer; Cancer metabolism; Cell death; Channel; Cholesterol; Hexokinase; Hypoxia; Mitochondria; Mitochondrial porin; VDAC

Indexed keywords

ACROLEIN; ANTINEOPLASTIC AGENT; AVICIN; CALCIUM ION; CELL PROTEIN; CHOLESTEROL; CISPLATIN; CYTOCHROME C; ENDOSTATIN; ERASTIN; FLUOXETINE; HEXOKINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OBLIMERSEN; PRLX 93936; PROTEIN BCL 2; PROTEIN TSPO; TRITERPENOID; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

APOPTOSIS; CALCIUM TRANSPORT; CANCER CELL; CANCER THERAPY; CELL CYCLE; CELL DEATH; CELL METABOLISM; CHOLESTEROL SYNTHESIS; ENDOPLASMIC RETICULUM; ENZYME RELEASE; GLYCOLYSIS; HUMAN; MITOCHONDRION; MOLECULAR INTERACTION; NEOPLASM; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; TUMOR CELL; UPREGULATION;

APOPTOSIS REGULATORY PROTEINS; CELL SURVIVAL; HEXOKINASE; HUMANS; MITOCHONDRIAL PROTEINS; MOLECULAR TARGETED THERAPY; NEOPLASMS; VOLTAGE-DEPENDENT ANION CHANNEL 1;

EID: 84857757702     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712798992110     Document Type: Review

References (382)

1. Schein, S. J.; Colombini, M.; Finkelstein, A. Reconstitution in planar lipid bilayers of a voltage-dependent anion-selective channel obtained from paramecium mitochondria. J. Membr. Biol., 1976, 30(2), 99-120. (Pubitemid 8010351)
2. Colombini, M. A candidate for the permeability pathway of the outer mitochondrial membrane. Nature, 1979, 279(5714), 643-645. (Pubitemid 9198862)
3. Colombini, M. Structure and mode of action of a voltage dependent anionselective channel (VDAC) located in the outer mitochondrial membrane. Ann. N. Y. Acad. Sci., 1980, 341, 552-563.
4. De Stefani, D.; Bononi, A.; Romagnoli, A.; Messina, A.; De Pinto, V.; Pinton, P.; Rizzuto, R. VDAC1 selectively transfers apoptotic Ca(2+) signals to mitochondria. Cell Death Differ., 2011.
5. Shoshan-Barmatz, V.; De Pinto, V.; Zweckstetter, M.; Raviv, Z.; Keinan, N.; Arbel, N. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol. Aspects Med., 2010, 31(3), 227-285.
6. Bayrhuber, M.; Meins, T.; Habeck, M.; Becker, S.; Giller, K.; Villinger, S.; Vonrhein, C.; Griesinger, C.; Zweckstetter, M.; Zeth, K. Structure of the human voltage-dependent anion channel. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(40), 15370-15375.
7. Hiller, S.; Garces, R. G.; Malia, T. J.; Orekhov, V. Y.; Colombini, M.; Wagner, G. Solution structure of the integral human membrane protein VDAC-1 in detergent micelles. Science, 2008, 321(5893), 1206-1210.
8. Ujwal, R.; Cascio, D.; Colletier, J. P.; Faham, S.; Zhang, J.; Toro, L.; Ping, P.; Abramson, J. The crystal structure of mouse VDAC1 at 2.3 A resolution reveals mechanistic insights into metabolite gating. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(46), 17742-17747.
9. Fiek, C.; Benz, R.; Roos, N.; Brdiczka, D. Evidence for identity between the hexokinase-binding protein and the mitochondrial porin in the outer membrane of rat liver mitochondria. Biochim. Biophys. Acta, 1982, 688(2), 429-440.
10. Shimizu, S.; Narita, M.; Tsujimoto, Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 1999, 399(6735), 483-487. (Pubitemid 29258855)
11. Shimizu, S.; Konishi, A.; Kodama, T.; Tsujimoto, Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. U. S. A., 2000, 97(7), 3100-3105. (Pubitemid 30183262)
12. Sugiyama, T.; Shimizu, S.; Matsuoka, Y.; Yoneda, Y.; Tsujimoto, Y. Activation of mitochondrial voltage-dependent anion channel by a proapoptotic BH3-only protein Bim. Oncogene, 2002, 21(32), 4944-4956.
13. Tsujimoto, Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J. Cell. Physiol., 2003, 195(2), 158-167. (Pubitemid 36384290)
14. Tajeddine, N.; Galluzzi, L.; Kepp, O.; Hangen, E.; Morselli, E.; Senovilla, L.; Araujo, N.; Pinna, G.; Larochette, N.; Zamzami, N.; Modjtahedi, N.; Harel-Bellan, A.; Kroemer, G. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene, 2008, 27(30), 4221-4232. (Pubitemid 351969915)
15. Arbel, N.; Shoshan-Barmatz, V. Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity. J. Biol. Chem., 2009, 285(9), 6053-6062.
16. Abu-Hamad, S.; Sivan, S.; Shoshan-Barmatz, V. The expression level of the voltage-dependent anion channel controls life and death of the cell. Proc. Natl. Acad. Sci. U. S. A., 2006, 103(15), 5787-5792.
17. Shoshan-Barmatz, V.; Gincel, D. The voltage-dependent anion channel: Characterization, modulation, and role in mitochondrial function in cell life and death. Cell Biochem. Biophys., 2003, 39(3), 279-292. (Pubitemid 41270796)
18. Azoulay-Zohar, H.; Israelson, A.; Abu-Hamad, S.; Shoshan-Barmatz, V. In self-defence: Hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem. J., 2004, 377(Pt 2), 347-355. (Pubitemid 38142190)
19. Zaid, H.; Abu-Hamad, S.; Israelson, A.; Nathan, I.; Shoshan-Barmatz, V. The voltage-dependent anion channel-1 modulates apoptotic cell death. Cell Death Differ., 2005, 12(7), 751-760. (Pubitemid 40945982)
20. Shoshan-Barmatz, V.; Zakar, M.; Rosenthal, K.; Abu-Hamad, S. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase. Biochim. Biophys. Acta, 2009, 1787(5), 421-430.
21. Shoshan-Barmatz, V.; Ben-Hail, D. VDAC, a multi-functional mitochondrial protein as a pharmacological target. Mitochondrion, 2011.
22. Benz, R. Permeation of hydrophilic solutes through mitochondrial outer membranes: Review on mitochondrial porins. Biochim. Biophys. Acta, 1994, 1197(2), 167-196.
23. Sampson, M. J.; Ross, L.; Decker, W. K.; Craigen, W. J. A novel isoform of the mitochondrial outer membrane protein VDAC3 via alternative splicing of a 3-base exon. Functional characteristics and subcellular localization. J. Biol. Chem., 1998, 273(46), 30482-30486. (Pubitemid 28545523)
24. Colombini, M. VDAC: The channel at the interface between mitochondria and the cytosol. Mol. Cell. Biochem., 2004, 256-257(1-2), 107-115. (Pubitemid 38181239)
25. Cesar Mde, C.; Wilson, J. E. All three isoforms of the voltage-dependent anion channel (VDAC1, VDAC2, and VDAC3) are present in mitochondria from bovine, rabbit, and rat brain. Arch. Biochem. Biophys., 2004, 422(2), 191-196. (Pubitemid 38169366)
26. De Pinto, V.; Guarino, F.; Guarnera, A.; Messina, A.; Reina, S.; Tomasello, F. M.; Palermo, V.; Mazzoni, C. Characterization of human VDAC isoforms: A peculiar function for VDAC3? Biochim. Biophys. Acta, 2010, 1797(6-7), 1268-1275.
27. Yamamoto, T.; Yamada, A.; Watanabe, M.; Yoshimura, Y.; Yamazaki, N.; Yoshimura, Y.; Yamauchi, T.; Kataoka, M.; Nagata, T.; Terada, H.; Shinohara, Y. VDAC1, having a shorter N-terminus than VDAC2 but showing the same migration in an SDS-polyacrylamide gel, is the predominant form expressed in mitochondria of various tissues. J. Proteome. Res., 2006, 5(12), 3336-3344. (Pubitemid 44904325)
28. Sampson, M. J.; Lovell, R. S.; Craigen, W. J. The murine voltage-dependent anion channel gene family. Conserved structure and function. J. Biol. Chem., 1997, 272(30), 18966-18973. (Pubitemid 27318251)
29. Wu, S.; Sampson, M. J.; Decker, W. K.; Craigen, W. J. Each mammalian mitochondrial outer membrane porin protein is dispensable: Effects on cellular respiration. Biochim. Biophys. Acta, 1999, 1452(1), 68-78. (Pubitemid 29486743)
30. Xu, X.; Decker, W.; Sampson, M. J.; Craigen, W. J.; Colombini, M. Mouse VDAC isoforms expressed in yeast: Channel properties and their roles in mitochondrial outer membrane permeability. J. Membr. Biol., 1999, 170(2), 89-102. (Pubitemid 29367689)
31. Anflous-Pharayra, K.; Lee, N.; Armstrong, D. L.; Craigen, W. J. VDAC3 has differing mitochondrial functions in two types of striated muscles. Biochim. Biophys. Acta, 2010, 1807(1), 150-156.
32. Sampson, M. J.; Decker, W. K.; Beaudet, A. L.; Ruitenbeek, W.; Armstrong, D.; Hicks, M. J.; Craigen, W. J. Immotile sperm and infertility in mice lacking mitochondrial voltage-dependent anion channel type 3. J. Biol. Chem., 2001, 276(42), 39206-39212.
33. Weeber, E. J.; Levy, M.; Sampson, M. J.; Anflous, K.; Armstrong, D. L.; Brown, S. E.; Sweatt, J. D.; Craigen, W. J. The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. J. Biol. Chem., 2002, 277(21), 18891-18897. (Pubitemid 34952449)
34. Blachly-Dyson, E.; Zambronicz, E. B.; Yu, W. H.; Adams, V.; McCabe, E. R.; Adelman, J.; Colombini, M.; Forte, M. Cloning and functional expression in yeast of two human isoforms of the outer mitochondrial membrane channel, the voltage-dependent anion channel. J. Biol. Chem., 1993, 268(3), 1835-1841. (Pubitemid 23033582)
35. Azoulay-Zohar, H.; Aflalo, C. Binding of rat brain hexokinase to recombinant yeast mitochondria: Identification of necessary molecular determinants. J. Bioenerg. Biomembr., 1999, 31(6), 569-579. (Pubitemid 30082900)
36. Neumann, D.; Buckers, J.; Kastrup, L.; Hell, S. W.; Jakobs, S. Two-color STED microscopy reveals different degrees of colocalization between hexokinase-I and the three human VDAC isoforms. PMC Biophys., 2010, 3(1), 4.
37. Youle, R. J.; Strasser, A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol, 2008, 9(1), 47-59.
38. Pastorino, J. G.; Hoek, J. B. Regulation of hexokinase binding to VDAC. J. Bioenerg. Biomembr., 2008, 40(3), 171-182.
39. Pastorino, J. G.; Hoek, J. B. Hexokinase II: The integration of energy metabolism and control of apoptosis. Curr. Med. Chem., 2003, 10(16), 1535-1551. (Pubitemid 36896555)
40. Cheng, E. H.; Sheiko, T. V.; Fisher, J. K.; Craigen, W. J.; Korsmeyer, S. J. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science, 2003, 301(5632), 513-517. (Pubitemid 36900308)
41. Gauci, S.; Helbig, A. O.; Slijper, M.; Krijgsveld, J.; Heck, A. J.; Mohammed, S. Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal. Chem., 2009, 81(11), 4493-4501.
42. Distler, A. M.; Kerner, J.; Hoppel, C. L. Post-translational modifications of rat liver mitochondrial outer membrane proteins identified by mass spectrometry. Biochim. Biophys. Acta, 2007, 1774(5), 628-636. (Pubitemid 46670809)
43. Choudhary, C.; Kumar, C.; Gnad, F.; Nielsen, M. L.; Rehman, M.; Walther, T. C.; Olsen, J. V.; Mann, M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science, 2009, 325(5942), 834-840.
44. Wang, B.; Malik, R.; Nigg, E. A.; Korner, R. Evaluation of the lowspecificity protease elastase for large-scale phosphoproteome analysis. Anal. Chem., 2008, 80(24), 9526-9533.
45. Kayser, H.; Kratzin, H. D.; Thinnes, F. P.; Gotz, H.; Schmidt, W. E.; Eckart, K.; Hilschmann, N. [Identification of human porins. II. Characterization and primary structure of a 31-lDa porin from human B lymphocytes (Porin 31HL)]. Biol. Chem. Hoppe. Seyler, 1989, 370(12), 1265-1278. (Pubitemid 20063280)
46. Hiller, S.; Wagner, G. The role of solution NMR in the structure determinations of VDAC-1 and other membrane proteins. Curr. Opin. Struct. Biol., 2009, 19(4), 396-401.
47. Koppel, D. A.; Kinnally, K. W.; Masters, P.; Forte, M.; Blachly-Dyson, E.; Mannella, C. A. Bacterial expression and characterization of the mitochondrial outer membrane channel. Effects of n-terminal modifications. J. Biol. Chem., 1998, 273(22), 13794-13800. (Pubitemid 28268429)
48. Mannella, C. A. Minireview: On the structure and gating mechanism of the mitochondrial channel, VDAC. J. Bioenerg. Biomembr., 1997, 29(6), 525-531. (Pubitemid 28164857)
49. Junankar, P. R.; Dulhunty, A. F.; Curtis, S. M.; Pace, S. M.; Thinnes, F. P. Porin-type 1 proteins in sarcoplasmic reticulum and plasmalemma of striated muscle fibres. J. Muscle Res. Cell Motil., 1995, 16(6), 595-610.
50. Shoshan-Barmatz, V.; Zalk, R.; Gincel, D.; Vardi, N. Subcellular localization of VDAC in mitochondria and ER in the cerebellum. Biochim. Biophys. Acta, 2004, 1657(2-3), 105-114. (Pubitemid 38952871)
51. Abu-Hamad, S.; Arbel, N.; Calo, D.; Arzoine, L.; Israelson, A.; Keinan, N.; Ben-Romano, R.; Friedman, O.; Shoshan-Barmatz, V. The VDAC1 Nterminus is essential both for apoptosis and the protective effect of antiapoptotic proteins. J. Cell Sci., 2009, 122(Pt 11), 1906-1916.
52. Shi, Y.; Chen, J.; Weng, C.; Chen, R.; Zheng, Y.; Chen, Q.; Tang, H. Identification of the protein-protein contact site and interaction mode of human VDAC1 with Bcl-2 family proteins. Biochem. Biophys. Res. Commun., 2003, 305(4), 989-996. (Pubitemid 36597861)
53. Malia, T. J.; Wagner, G. NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL. Biochemistry (Mosc). 2007, 46(2), 514-525. (Pubitemid 46105440)
54. Shoshan-Barmatz, V.; Keinan, N.; Zaid, H. Uncovering the role of VDAC in the regulation of cell life and death. J. Bioenerg. Biomembr., 2008, 40(3), 183-191.
55. Zalk, R.; Israelson, A.; Garty, E. S.; Azoulay-Zohar, H.; Shoshan-Barmatz, V. Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria. Biochem. J., 2005, 386(Pt 1), 73-83. (Pubitemid 40289226)
56. Zeth, K.; Meins, T.; Vonrhein, C. Approaching the structure of human VDAC1, a key molecule in mitochondrial cross-talk. J. Bioenerg. Biomembr., 2008, 40(3), 127-132.
57. Hoogenboom, B. W.; Suda, K.; Engel, A.; Fotiadis, D. The supramolecular assemblies of voltage-dependent anion channels in the native membrane. J. Mol. Biol., 2007, 370(2), 246-255. (Pubitemid 46829218)
58. Goncalves, R. P.; Buzhynskyy, N.; Prima, V.; Sturgis, J. N.; Scheuring, S. Supramolecular assembly of VDAC in native mitochondrial outer membranes. J. Mol. Biol., 2007, 369(2), 413-418. (Pubitemid 46678059)
59. Keinan, N.; Tyomkin, D.; Shoshan-Barmatz, V. Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis. Mol. Cell. Biol., 2010, 30(24), 5698-5709.
60. Shoshan-Barmatz, V.; Arbel, N.; Arzoine, L. VDAC, the voltage-dependent anion channel: Function, regulation & mitochondrial signaling in cell life and death. Cell Sci., 2008, 4, 74-118.
61. Guo, X. W.; Smith, P. R.; Cognon, B.; D'Arcangelis, D.; Dolginova, E.; Mannella, C. A. Molecular design of the voltage-dependent, anion-selective channel in the mitochondrial outer membrane. J. Struct. Biol., 1995, 114(1), 41-59.
62. Ujwal, R.; Cascio, D.; Chaptal, V.; Ping, P.; Abramson, J. Crystal packing analysis of murine VDAC1 crystals in a lipidic environment reveals novel insights on oligomerization and orientation. Channels (Austin), 2009, 3(3), 167-170.
63. Linden, M.; Gellerfors, P.; Nelson, B. D. Pore protein and the hexokinasebinding protein from the outer membrane of rat liver mitochondria are identical. FEBS Lett., 1982, 141(2), 189-192.
64. Gincel, D.; Silberberg, S. D.; Shoshan-Barmatz, V. Modulation of the voltage-dependent anion channel (VDAC) by glutamate. J. Bioenerg. Biomembr., 2000, 32(6), 571-583. (Pubitemid 32204234)
65. De Pinto, V.; Tommasino, M.; Benz, R.; Palmieri, F. The 35 kDa DCCDbinding protein from pig heart mitochondria is the mitochondrial porin. Biochim. Biophys. Acta, 1985, 813(2), 230-242. (Pubitemid 15141018)
66. Mannella, C. A.; Guo, X. W.; Cognon, B. Diameter of the mitochondrial outer membrane channel: Evidence from electron microscopy of frozenhydrated membrane crystals. FEBS Lett., 1989, 253, 231-234. (Pubitemid 19212569)
67. Hodge, T.; Colombini, M. Regulation of metabolite flux through voltagegating of VDAC channels. J. Membr. Biol., 1997, 157(3), 271-279. (Pubitemid 27276169)
68. Rostovtseva, T.; Colombini, M. VDAC channels mediate and gate the flow of ATP: Implications for the regulation of mitochondrial function. Biophys. J., 1997, 72(5), 1954-1962. (Pubitemid 27184425)
69. Benz, R.; Kottke, M.; Brdiczka, D. The cationically selective state of the mitochondrial outer membrane pore: A study with intact mitochondria and reconstituted mitochondrial porin. Biochim. Biophys. Acta, 1990, 1022(3), 311-318. (Pubitemid 20079112)
70. Shoshan-Barmatz, V.; Israelson, A. The voltage-dependent anion channel in endoplasmic/sarcoplasmic reticulum: Characterization, modulation and possible function. J. Membr. Biol., 2005, 204(2), 57-66. (Pubitemid 41285537)
71. Gincel, D.; Zaid, H.; Shoshan-Barmatz, V. Calcium binding and translocation by the voltage-dependent anion channel: A possible regulatory mechanism in mitochondrial function. Biochem. J., 2001, 358(Pt 1), 147-155. (Pubitemid 32778108)
72. Lee, A. C.; Zizi, M.; Colombini, M. Beta-NADH decreases the permeability of the mitochondrial outer membrane to ADP by a factor of 6. J. Biol. Chem., 1994, 269(49), 30974-30980. (Pubitemid 24377586)
73. Zizi, M.; Forte, M.; Blachly-Dyson, E.; Colombini, M. NADH regulates the gating of VDAC, the mitochondrial outer membrane channel. J. Biol. Chem., 1994, 269(3), 1614-1616. (Pubitemid 24035349)
74. Rostovtseva, T.; Colombini, M. ATP flux is controlled by a voltage-gated channel from the mitochondrial outer membrane. J. Biol. Chem., 1996, 271(45), 28006-28008. (Pubitemid 26374603)
75. Rostovtseva, T. K.; Komarov, A.; Bezrukov, S. M.; Colombini, M. Dynamics of nucleotides in VDAC channels: Structure-specific noise generation. Biophys. J., 2002, 82(1 Pt 1), 193-205. (Pubitemid 34289794)
76. Yehezkel, G.; Hadad, N.; Zaid, H.; Sivan, S.; Shoshan-Barmatz, V. Nucleotide-binding sites in the voltage-dependent anion channel: Characterization and localization. J. Biol. Chem., 2006, 281(9), 5938-5946. (Pubitemid 43847694)
77. Gincel, D.; Shoshan-Barmatz, V. Glutamate interacts with VDAC and modulates opening of the mitochondrial permeability transition pore. J. Bioenerg. Biomembr., 2004, 36(2), 179-186. (Pubitemid 39023635)
78. Colombini, M.; Yeung, C. L.; Tung, J.; Konig, T. The mitochondrial outer membrane channel, VDAC, is regulated by a synthetic polyanion. Biochim. Biophys. Acta, 1987, 905(2), 279-286. (Pubitemid 18004526)
79. Lai, J. C.; Tan, W.; Benimetskaya, L.; Miller, P.; Colombini, M.; Stein, C. A. A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC. Proc. Natl. Acad. Sci. U. S. A., 2006, 103(19), 7494-7499. (Pubitemid 43727861)
80. Berridge, M. J.; Lipp, P.; Bootman, M. D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol., 2000, 1(1), 11-21.
81. Cardenas, C.; Miller, R. A.; Smith, I.; Bui, T.; Molgo, J.; Muller, M.; Vais, H.; Cheung, K. H.; Yang, J.; Parker, I.; Thompson, C. B.; Birnbaum, M. J.; Hallows, K. R.; Foskett, J. K. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell, 2010, 142(2), 270-283.
82. Kinnally, K. W.; Peixoto, P. M.; Ryu, S. Y.; Dejean, L. M. Is mPTP the gatekeeper for necrosis, apoptosis, or both? Biochim. Biophys. Acta, 2011, 1813(4), 616-622.
83. Rasola, A.; Bernardi, P. Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis. Cell Calcium, 2011.
84. Crompton, M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J., 1999, 341 ( Pt 2), 233-249. (Pubitemid 29373645)
85. Starkov, A. A. The molecular identity of the mitochondrial Ca2+ sequestration system. FEBS J., 2010, 277(18), 3652-3663.
86. Baughman, J. M.; Perocchi, F.; Girgis, H. S.; Plovanich, M.; Belcher-Timme, C. A.; Sancak, Y.; Bao, X. R.; Strittmatter, L.; Goldberger, O.; Bogorad, R. L.; Koteliansky, V.; Mootha, V. K. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature, 2011.
87. De Stefani, D.; Raffaello, A.; Teardo, E.; Szabo, I.; Rizzuto, R. A fortykilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature, 2011.
88. Palty, R.; Silverman, W. F.; Hershfinkel, M.; Caporale, T.; Sensi, S. L.; Parnis, J.; Nolte, C.; Fishman, D.; Shoshan-Barmatz, V.; Herrmann, S.; Khananshvili, D.; Sekler, I. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc. Natl. Acad. Sci. U. S. A., 2010, 107(1), 436-441.
89. Tan, W.; Colombini, M. VDAC closure increases calcium ion flux. Biochim. Biophys. Acta, 2007, 1768(10), 2510-2515. (Pubitemid 47532032)
90. Gincel, D.; Vardi, N.; Shoshan-Barmatz, V. Retinal voltage-dependent anion channel: Characterization and cellular localization. Invest. Ophthalmol. Vis. Sci., 2002, 43(7), 2097-2104. (Pubitemid 34700633)
91. Israelson, A.; Arzoine, L.; Abu-hamad, S.; Khodorkovsky, V.; Shoshan-Barmatz, V. A photoactivable probe for calcium binding proteins. Chem. Biol., 2005, 12(11), 1169-1178. (Pubitemid 41628252)
92. De Pinto, V.; al Jamal, J. A.; Palmieri, F. Location of the dicyclohexylcarbodiimide-reactive glutamate residue in the bovine heart mitochondrial porin. J. Biol. Chem., 1993, 268(17), 12977-12982. (Pubitemid 23182473)
93. Shafir, I.; Feng, W.; Shoshan-Barmataz, V. Voltage-dependent anion channel proteins in synaptosomes of the torpedo electric organ: Immunolocalization, purification, and characterization. J. Bioenerg. Biomembr., 1998, 30(5), 499-510. (Pubitemid 29050976)
94. Shoshan-Barmatz, V.; Hadad, N.; Feng, W.; Shafir, I.; Orr, I.; Varsanyi, M.; Heilmeyer, L. M. VDAC/porin is present in sarcoplasmic reticulum from skeletal muscle. FEBS Lett., 1996, 386(2-3), 205-210. (Pubitemid 26170141)
95. Bathori, G.; Csordas, G.; Garcia-Perez, C.; Davies, E.; Hajnoczky, G. Ca2+-dependent control of the permeability properties of the mitochondrial outer membrane and voltage-dependent anion-selective channel (VDAC). J. Biol. Chem., 2006, 281(25), 17347-17358.
96. Bae, J. H.; Park, J. W.; Kwon, T. K. Ruthenium red, inhibitor of mitochondrial Ca2+ uniporter, inhibits curcumin-induced apoptosis via the prevention of intracellular Ca2+ depletion and cytochrome c release. Biochem. Biophys. Res. Commun., 2003, 303(4), 1073-1079. (Pubitemid 36390254)
97. Baek, J. H.; Lee, Y. S.; Kang, C. M.; Kim, J. A.; Kwon, K. S.; Son, H. C.; Kim, K. W. Intracellular Ca2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int. J. Cancer, 1997, 73(5), 725-728. (Pubitemid 127483071)
98. Ding, W. X.; Shen, H. M.; Ong, C. N. Pivotal role of mitochondrial Ca(2+) in microcystin-induced mitochondrial permeability transition in rat hepatocytes. Biochem. Biophys. Res. Commun., 2001, 285(5), 1155-1161.
99. Chandra, J.; Mansson, E.; Gogvadze, V.; Kaufmann, S. H.; Albertioni, F.; Orrenius, S. Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release. Blood, 2002, 99(2), 655-663. (Pubitemid 34533105)
100. Papp, B.; Brouland, J. P.; Gelebart, P.; Kovacs, T.; Chomienne, C. Endoplasmic reticulum calcium transport ATPase expression during differentiation of colon cancer and leukaemia cells. Biochem. Biophys. Res. Commun., 2004, 322(4), 1223-1236. (Pubitemid 39164652)
101. Brenner, C.; Grimm, S. The permeability transition pore complex in cancer cell death. Oncogene, 2006, 25(34), 4744-4756. (Pubitemid 44192088)
102. Decuypere, J. P.; Monaco, G.; Missiaen, L.; De Smedt, H.; Parys, J. B.; Bultynck, G. IP(3) Receptors, Mitochondria, and Ca Signaling: Implications for Aging. J. Aging Res., 2011, 2011, 920178.
103. Hajnoczky, G.; Davies, E.; Madesh, M. Calcium signaling and apoptosis. Biochem. Biophys. Res. Commun., 2003, 304(3), 445-454. (Pubitemid 36506516)
104. Pinton, P.; Giorgi, C.; Siviero, R.; Zecchini, E.; Rizzuto, R. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene, 2008, 27(50), 6407-6418.
105. Deniaud, A.; Sharaf el dein, O.; Maillier, E.; Poncet, D.; Kroemer, G.; Lemaire, C.; Brenner, C. Endoplasmic reticulum stress induces calciumdependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene, 2008, 27(3), 285-299.
106. Pinton, P.; Ferrari, D.; Rapizzi, E.; Di Virgilio, F.; Pozzan, T.; Rizzuto, R. A role for calcium in Bcl-2 action? Biochimie, 2002, 84(2-3), 195-201.
107. Rapizzi, E.; Pinton, P.; Szabadkai, G.; Wieckowski, M. R.; Vandecasteele, G.; Baird, G.; Tuft, R. A.; Fogarty, K. E.; Rizzuto, R. Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. J. Cell Biol., 2002, 159(4), 613-624.
108. Szabadkai, G.; Bianchi, K.; Varnai, P.; De Stefani, D.; Wieckowski, M. R.; Cavagna, D.; Nagy, A. I.; Balla, T.; Rizzuto, R. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J. Cell Biol., 2006, 175(6), 901-911. (Pubitemid 44969196)
109. Mares-Perlman, J. A.; Shrago, E. Energy substrate utilization in freshly isolated Morris Hepatoma 7777 cells. Cancer Res., 1988, 48(3), 602-608. (Pubitemid 18056528)
110. Baggetto, L. G.; Clottes, E.; Vial, C. Low mitochondrial proton leak due to high membrane cholesterol content and cytosolic creatine kinase as two features of the deviant bioenergetics of Ehrlich and AS30-D tumor cells. Cancer Res., 1992, 52(18), 4935-4941.
111. Pedersen, P. L. Tumor mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumor Res., 1978, 22, 190-274.
112. Yu, W.; Gong, J. S.; Ko, M.; Garver, W. S.; Yanagisawa, K.; Michikawa, M. Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J. Biol. Chem., 2005, 280(12), 11731-11739. (Pubitemid 40418487)
113. Epand, R. M. Cholesterol and the interaction of proteins with membrane domains. Prog. Lipid Res., 2006, 45(4), 279-294. (Pubitemid 43818129)
114. Campbell, A. M.; Chan, S. H. The voltage dependent anion channel affects mitochondrial cholesterol distribution and function. Arch. Biochem. Biophys., 2007, 466(2), 203-210. (Pubitemid 47451339)
115. Cafforio, P.; Dammacco, F.; Gernone, A.; Silvestris, F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis, 2005, 26(5), 883-891. (Pubitemid 41214316)
116. Li, H. Y.; Appelbaum, F. R.; Willman, C. L.; Zager, R. A.; Banker, D. E. Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Blood, 2003, 101(9), 3628-3634. (Pubitemid 36857952)
117. Rone, M. B.; Fan, J.; Papadopoulos, V. Cholesterol transport in steroid biosynthesis: Role of protein-protein interactions and implications in disease states. Biochim. Biophys. Acta, 2009, 1791(7), 646-658.
118. Campbell, A. M.; Chan, S. H. Mitochondrial membrane cholesterol, the voltage dependent anion channel (VDAC), and the Warburg effect. J. Bioenerg. Biomembr., 2008, 40(3), 193-197.
119. Lisanti, M. P.; Scherer, P. E.; Vidugiriene, J.; Tang, Z.; Hermanowski-Vosatka, A.; Tu, Y. H.; Cook, R. F.; Sargiacomo, M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J. Cell Biol., 1994, 126(1), 111-126. (Pubitemid 24214933)
120. Bathori, G.; Parolini, I.; Szabo, I.; Tombola, F.; Messina, A.; Oliva, M.; Sargiacomo, M.; De Pinto, V.; Zoratti, M. Extramitochondrial porin: Facts and hypotheses. J. Bioenerg. Biomembr., 2000, 32(1), 79-89. (Pubitemid 30241260)
121. Darbandi-Tonkabon, R.; Hastings, W. R.; Zeng, C. M.; Akk, G.; Manion, B. D.; Bracamontes, J. R.; Steinbach, J. H.; Mennerick, S. J.; Covey, D. F.; Evers, A. S. Photoaffinity labeling with a neuroactive steroid analogue. 6-Azi-pregnanolone labels voltage-dependent anion channel-1 in rat brain. J. Biol. Chem., 2003, 278(15), 13196-13206. (Pubitemid 36800089)
122. Jancsik, V.; Linden, M.; Dorbani, L.; Rendon, A.; Nelson, B. D. Studies on the relationship between the inner and outer membranes of rat liver mitochondria as determined by subfractionation with digitonin. Arch. Biochem. Biophys., 1988, 264(1), 295-301.
123. De Pinto, V.; Benz, R.; Palmieri, F. Interaction of non-classical detergents with the mitochondrial porin. A new purification procedure and characterization of the pore-forming unit. Eur. J. Biochem., 1989, 183(1), 179-187. (Pubitemid 19185266)
124. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol., 2007, 35(4), 495-516. (Pubitemid 46911891)
125. Yasuhara, S.; Asai, A.; Sahani, N. D.; Martyn, J. A. Mitochondria, endoplasmic reticulum, and alternative pathways of cell death in critical illness. Crit. Care Med., 2007, 35(9 Suppl), S488-495. (Pubitemid 47312184)
126. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell, 2000, 100(1), 57-70. (Pubitemid 30046295)
127. Green, D. R. Apoptotic pathways: Paper wraps stone blunts scissors. Cell, 2000, 102(1), 1-4.
128. Delhalle, S.; Duvoix, A.; Schnekenburger, M.; Morceau, F.; Dicato, M.; Diederich, M. An introduction to the molecular mechanisms of apoptosis. Ann. N. Y. Acad. Sci., 2003, 1010, 1-8. (Pubitemid 38264943)
129. Almasan, A.; Ashkenazi, A. Apo2L/TRAIL: Apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev., 2003, 14(3-4), 337-348. (Pubitemid 36693152)
130. Baines, C. P.; Song, C. X.; Zheng, Y. T.; Wang, G. W.; Zhang, J.; Wang, O. L.; Guo, Y.; Bolli, R.; Cardwell, E. M.; Ping, P. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ. Res., 2003, 92(8), 873-880. (Pubitemid 36542528)
131. Kumar, R.; Herbert, P. E.; Warrens, A. N. An introduction to death receptors in apoptosis. Int. J. Surg., 2005, 3(4), 268-277. (Pubitemid 43129687)
132. Wenner, C. E. Targeting mitochondria as a therapeutic target in cancer. J. Cell. Physiol., 2011.
133. Keeble, J. A.; Gilmore, A. P. Apoptosis commitment-translating survival signals into decisions on mitochondria. Cell Res., 2007, 17(12), 976-984. (Pubitemid 350261795)
134. Kroemer, G.; Galluzzi, L.; Brenner, C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev., 2007, 87(1), 99-163. (Pubitemid 46209992)
135. Le Bras, M.; Clement, M. V.; Pervaiz, S.; Brenner, C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol. Histopathol., 2005, 20(1), 205-219.
136. Denning, M. F.; Wang, Y.; Tibudan, S.; Alkan, S.; Nickoloff, B. J.; Qin, J. Z. Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ., 2002, 9(1), 40-52. (Pubitemid 34071992)
137. Antonsson, B. Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways. Mol. Cell. Biochem., 2004, 256-257(1-2), 141-155. (Pubitemid 38181242)
138. Gottlieb, R. A. Role of mitochondria in apoptosis. Crit. Rev. Eukaryot. Gene Expr., 2000, 10(3-4), 231-239. (Pubitemid 32155135)
139. Green, D. R.; Kroemer, G. The pathophysiology of mitochondrial cell death. Science, 2004, 305(5684), 626-629. (Pubitemid 39006738)
140. Cory, S.; Adams, J. M. The Bcl2 family: Regulators of the cellular life-ordeath switch. Nat. Rev. Cancer, 2002, 2(9), 647-656. (Pubitemid 37328916)
141. Altieri, D. C. Survivin and IAP proteins in cell-death mechanisms. Biochem. J., 2010, 430(2), 199-205.
142. Yuste, V. J.; Moubarak, R. S.; Delettre, C.; Bras, M.; Sancho, P.; Robert, N.; d'Alayer, J.; Susin, S. A. Cysteine protease inhibition prevents mitochondrial apoptosis-inducing factor (AIF) release. Cell Death Differ., 2005, 12(11), 1445-1448. (Pubitemid 41521936)
143. Susin, S. A.; Lorenzo, H. K.; Zamzami, N.; Marzo, I.; Snow, B. E.; Brothers, G. M.; Mangion, J.; Jacotot, E.; Costantini, P.; Loeffler, M.; Larochette, N.; Goodlett, D. R.; Aebersold, R.; Siderovski, D. P.; Penninger, J. M.; Kroemer, G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 1999, 397(6718), 441-446.
144. Kantari, C.; Walczak, H. Caspase-8 and bid: Caught in the act between death receptors and mitochondria. Biochim. Biophys. Acta, 2011, 1813(4), 558-563.
145. Lemasters, J. J.; Holmuhamedov, E. Voltage-dependent anion channel (VDAC) as mitochondrial governator-thinking outside the box. Biochim. Biophys. Acta, 2006, 1762(2), 181-190. (Pubitemid 43006024)
146. Vander Heiden, M. G.; Chandel, N. S.; Li, X. X.; Schumacker, P. T.; Colombini, M.; Thompson, C. B. Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc. Natl. Acad. Sci. U. S. A., 2000, 97(9), 4666-4671. (Pubitemid 30238615)
147. Vander Heiden, M. G.; Li, X. X.; Gottleib, E.; Hill, R. B.; Thompson, C. B.; Colombini, M. Bcl-xL promotes the open configuration of the voltagedependent anion channel and metabolite passage through the outer mitochondrial membrane. J. Biol. Chem., 2001, 276(22), 19414-19419.
148. Bernardi, P. Mitochondrial transport of cations: Channels, exchangers, and permeability transition. Physiol. Rev., 1999, 79(4), 1127-1155. (Pubitemid 29473313)
149. Halestrap, A. P.; Doran, E.; Gillespie, J. P.; O'Toole, A. Mitochondria and cell death. Biochem. Soc. Trans., 2000, 28(2), 170-177. (Pubitemid 30103235)
150. Lemasters, J. J.; Qian, T.; Bradham, C. A.; Brenner, D. A.; Cascio, W. E.; Trost, L. C.; Nishimura, Y.; Nieminen, A. L.; Herman, B. Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J. Bioenerg. Biomembr., 1999, 31(4), 305-319. (Pubitemid 30058566)
151. Green, D. R.; Evan, G. I. A matter of life and death. Cancer Cell, 2002, 1(1), 19-30. (Pubitemid 41039172)
152. Tsujimoto, Y.; Shimizu, S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis, 2007, 12(5), 835-840. (Pubitemid 46653286)
153. Kokoszka, J. E.; Waymire, K. G.; Levy, S. E.; Sligh, J. E.; Cai, J.; Jones, D. P.; MacGregor, G. R.; Wallace, D. C. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature, 2004, 427(6973), 461-465. (Pubitemid 38168501)
154. Baines, C. P.; Kaiser, R. A.; Purcell, N. H.; Blair, N. S.; Osinska, H.; Hambleton, M. A.; Brunskill, E. W.; Sayen, M. R.; Gottlieb, R. A.; Dorn, G. W.; Robbins, J.; Molkentin, J. D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature, 2005, 434(7033), 658-662. (Pubitemid 40488559)
155. Baines, C. P.; Kaiser, R. A.; Sheiko, T.; Craigen, W. J.; Molkentin, J. D. Voltage-dependent anion channels are dispensable for mitochondrialdependent cell death. Nat. Cell Biol., 2007, 9(5), 550-555. (Pubitemid 46696536)
156. Antonsson, B.; Montessuit, S.; Lauper, S.; Eskes, R.; Martinou, J. C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem. J., 2000, 345 Pt 2, 271-278. (Pubitemid 30077167)
157. Antonsson, B.; Montessuit, S.; Sanchez, B.; Martinou, J. C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem., 2001, 276(15), 11615-11623.
158. Eskes, R.; Desagher, S.; Antonsson, B.; Martinou, J. C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol., 2000, 20(3), 929-935. (Pubitemid 30044230)
159. Reed, J. C. Proapoptotic multidomain Bcl-2/Bax-family proteins: Mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ., 2006, 13(8), 1378-1386. (Pubitemid 44057473)
160. Bleicken, S.; Classen, M.; Padmavathi, P. V.; Ishikawa, T.; Zeth, K.; Steinhoff, H. J.; Bordignon, E. Molecular details of Bax activation, oligomerization, and membrane insertion. J. Biol. Chem., 2010, 285(9), 6636-6647.
161. Zhang, Z.; Zhu, W.; Lapolla, S. M.; Miao, Y.; Shao, Y.; Falcone, M.; Boreham, D.; McFarlane, N.; Ding, J.; Johnson, A. E.; Zhang, X. C.; Andrews, D. W.; Lin, J. Bax forms an oligomer via separate, yet interdependent, surfaces. J. Biol. Chem., 2010, 285(23), 17614-17627.
162. Gavathiotis, E.; Suzuki, M.; Davis, M. L.; Pitter, K.; Bird, G. H.; Katz, S. G.; Tu, H. C.; Kim, H.; Cheng, E. H.; Tjandra, N.; Walensky, L. D. BAX activation is initiated at a novel interaction site. Nature, 2008, 455(7216), 1076-1081.
163. Antignani, A.; Youle, R. J. How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr. Opin. Cell Biol., 2006, 18(6), 685-689. (Pubitemid 44692478)
164. Lovell, J. F.; Billen, L. P.; Bindner, S.; Shamas-Din, A.; Fradin, C.; Leber, B.; Andrews, D. W. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell, 2008, 135(6), 1074-1084.
165. Banerjee, J.; Ghosh, S. Bax increases the pore size of rat brain mitochondrial voltage-dependent anion channel in the presence of tBid. Biochem. Biophys. Res. Commun., 2004, 323(1), 310-314. (Pubitemid 39206288)
166. Shimizu, S.; Tsujimoto, Y. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. Proc. Natl. Acad. Sci. U. S. A., 2000, 97(2), 577-582. (Pubitemid 30070351)
167. Kinnally, K. W.; Antonsson, B. A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis, 2007, 12(5), 857-868. (Pubitemid 46653291)
168. Martinez-Caballero, S.; Dejean, L. M.; Kinnally, M. S.; Oh, K. J.; Mannella, C. A.; Kinnally, K. W. Assembly of the mitochondrial apoptosis-induced channel, MAC. J. Biol. Chem., 2009, 284(18), 12235-12245.
169. Siskind, L. J.; Kolesnick, R. N.; Colombini, M. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion, 2006, 6(3), 118-125. (Pubitemid 43872021)
170. Stiban, J.; Caputo, L.; Colombini, M. Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins. J. Lipid Res., 2008, 49(3), 625-634.
171. Park, J. Y.; Kim, M. J.; Kim, Y. K.; Woo, J. S. Ceramide induces apoptosis via caspase-dependent and caspase-independent pathways in mesenchymal stem cells derived from human adipose tissue. Arch. Toxicol., 2011.
172. Shoshan-Barmatz, V.; Israelson, A.; Brdiczka, D.; Sheu, S. S. The voltagedependent anion channel (VDAC): Function in intracellular signalling, cell life and cell death. Curr. Pharm. Des., 2006, 12(18), 2249-2270. (Pubitemid 43891398)
173. Galluzzi, L.; Kroemer, G. Mitochondrial apoptosis without VDAC. Nat. Cell Biol., 2007, 9(5), 487-489. (Pubitemid 46696528)
174. Gogvadze, V.; Orrenius, S.; Zhivotovsky, B. Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim. Biophys. Acta, 2006, 1757(5-6), 639-647. (Pubitemid 43993852)
175. Rustin, P.; Kroemer, G. Mitochondria and Cancer. In: Oncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour Physiology; Kroemer, G.; Mumberg, D.; Keun, H.; Riefke, B.; Steger-Hartmann, T.; Petersen, K., Eds.; Springer Berlin Heidelberg: Berlin, 2008; Vol. 4, pp. 1-21.
176. Fulda, S. Tumor resistance to apoptosis. Int. J. Cancer, 2009, 124(3), 511-515.
177. Debatin, K. M.; Poncet, D.; Kroemer, G. Chemotherapy: Targeting the mitochondrial cell death pathway. Oncogene, 2002, 21(57), 8786-8803. (Pubitemid 36132400)
178. Ghobrial, I. M.; Witzig, T. E.; Adjei, A. A. Targeting apoptosis pathways in cancer therapy. CA. Cancer J. Clin., 2005, 55(3), 178-194. (Pubitemid 40826487)
179. Hail, N., Jr. Mitochondria: A novel target for the chemoprevention of cancer. Apoptosis, 2005, 10(4), 687-705. (Pubitemid 41187069)
180. Hu, W.; Kavanagh, J. J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol., 2003, 4(12), 721-729. (Pubitemid 37527207)
181. Ralph, S. J.; Neuzil, J. Mitochondria as targets for cancer therapy. Mol. Nutr. Food Res., 2009, 53(1), 9-28.
182. Isoldi, M. C.; Visconti, M. A.; Castrucci, A. M. Anti-cancer drugs: Molecular mechanisms of action. Mini Rev. Med. Chem., 2005, 5(7), 685-695. (Pubitemid 40933040)
183. Roos, W. P.; Kaina, B. DNA damage-induced cell death by apoptosis. Trends Mol. Med., 2006, 12(9), 440-450. (Pubitemid 44291571)
184. Decaudin, D.; Geley, S.; Hirsch, T.; Castedo, M.; Marchetti, P.; Macho, A.; Kofler, R.; Kroemer, G. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res., 1997, 57(1), 62-67. (Pubitemid 27020331)
185. Ravagnan, L.; Marzo, I.; Costantini, P.; Susin, S. A.; Zamzami, N.; Petit, P. X.; Hirsch, F.; Goulbern, M.; Poupon, M. F.; Miccoli, L.; Xie, Z.; Reed, J. C.; Kroemer, G. Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene, 1999, 18(16), 2537-2546. (Pubitemid 29216676)
186. Costantini, P.; Jacotot, E.; Decaudin, D.; Kroemer, G. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst., 2000, 92(13), 1042-1053. (Pubitemid 30616479)
187. Hu, J.; Fang, J.; Dong, Y.; Chen, S. J.; Chen, Z. Arsenic in cancer therapy. Anticancer. Drugs, 2005, 16(2), 119-127. (Pubitemid 40250606)
188. Kaufmann, S. H.; Earnshaw, W. C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res., 2000, 256(1), 42-49. (Pubitemid 30211165)
189. Albayrak, T.; Scherhammer, V.; Schoenfeld, N.; Braziulis, E.; Mund, T.; Bauer, M. K.; Scheffler, I. E.; Grimm, S. The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. Mol. Biol. Cell, 2003, 14(8), 3082-3096. (Pubitemid 37013112)
190. Zheng, Y.; Shi, Y.; Tian, C.; Jiang, C.; Jin, H.; Chen, J.; Almasan, A.; Tang, H.; Chen, Q. Essential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide. Oncogene, 2004, 23(6), 1239-1247. (Pubitemid 38297178)
191. Wenger, J. B.; Chun, S. Y.; Dang, D. T.; Luesch, H.; Dang, L. H. Combination therapy targeting cancer metabolism. Med. Hypotheses, 2011, 76(2), 169-172.
192. Gatenby, R. A.; Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer, 2004, 4(11), 891-899. (Pubitemid 39472955)
193. Kim, J. W.; Dang, C. V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res., 2006, 66(18), 8927-8930. (Pubitemid 44521105)
194. Mathupala, S. P.; Ko, Y. H.; Pedersen, P. L. Hexokinase II: Cancer's doubleedged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene, 2006, 25(34), 4777-4786. (Pubitemid 44187625)
195. Pedersen, P. L. Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J. Bioenerg. Biomembr., 2007, 39(3), 211-222. (Pubitemid 47619382)
196. Pedersen, P. L.; Mathupala, S.; Rempel, A.; Geschwind, J. F.; Ko, Y. H. Mitochondrial bound type II hexokinase: A key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim. Biophys. Acta, 2002, 1555(1-3), 14-20. (Pubitemid 35245999)
197. Warburg, O. On the origin of cancer cells. Science, 1956, 123(3191), 309-314.
198. Gambhir, S. S. Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer, 2002, 2(9), 683-693. (Pubitemid 37328919)
199. Mathupala, S. P.; Ko, Y. H.; Pedersen, P. L. Hexokinase-2 bound to mitochondria: Cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin. Cancer Biol., 2009, 19(1), 17-24.
200. Harvey, A. J.; Kind, K. L.; Thompson, J. G. REDOX regulation of early embryo development. Reproduction, 2002, 123(4), 479-486. (Pubitemid 34303149)
201. Vander Heiden, M. G.; Cantley, L. C.; Thompson, C. B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science, 2009, 324(5930), 1029-1033.
202. Simonnet, H.; Alazard, N.; Pfeiffer, K.; Gallou, C.; Beroud, C.; Demont, J.; Bouvier, R.; Schagger, H.; Godinot, C. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis, 2002, 23(5), 759-768. (Pubitemid 34567514)
203. Unwin, R. D.; Craven, R. A.; Harnden, P.; Hanrahan, S.; Totty, N.; Knowles, M.; Eardley, I.; Selby, P. J.; Banks, R. E. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics, 2003, 3(8), 1620-1632. (Pubitemid 37048086)
204. Meierhofer, D.; Mayr, J. A.; Foetschl, U.; Berger, A.; Fink, K.; Schmeller, N.; Hacker, G. W.; Hauser-Kronberger, C.; Kofler, B.; Sperl, W. Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis, 2004, 25(6), 1005-1010. (Pubitemid 38886085)
205. Koppenol, W. H.; Bounds, P. L.; Dang, C. V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer, 2011, 11(5), 325-337.
206. Abu-Hamad, S.; Zaid, H.; Israelson, A.; Nahon, E.; Shoshan-Barmatz, V. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: Mapping the site of binding. J. Biol. Chem., 2008, 283(19), 13482-13490.
207. Arzoine, L.; Zilberberg, N.; Ben-Romano, R.; Shoshan-Barmatz, V. Voltagedependent anion channel 1-based peptides interact with hexokinase to prevent its anti-Apoptotic activity. J. Biol. Chem., 2009, 284(6), 3946-3955.
208. Pastorino, J. G.; Hoek, J. B.; Shulga, N. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res., 2005, 65(22), 10545-10554. (Pubitemid 41743749)
209. Pastorino, J. G.; Shulga, N.; Hoek, J. B. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J. Biol. Chem., 2002, 277(9), 7610-7618. (Pubitemid 34953160)
210. Pedersen, P. L. Voltage dependent anion channels (VDACs): A brief introduction with a focus on the outer mitochondrial compartment's roles together with hexokinase-2 in the "Warburg effect" in cancer. J. Bioenerg. Biomembr., 2008, 40(3), 123-126.
211. Bustamante, E.; Pedersen, P. L. High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase. Proc. Natl. Acad. Sci. U. S. A., 1977, 74(9), 3735-3739. (Pubitemid 8189957)
212. Pouyssegur, J.; Dayan, F.; Mazure, N. M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature, 2006, 441(7092), 437-443. (Pubitemid 44050138)
213. Godinot, C.; de Laplanche, E.; Hervouet, E.; Simonnet, H. Actuality of Warburg's views in our understanding of renal cancer metabolism. J. Bioenerg. Biomembr., 2007, 39(3), 235-241. (Pubitemid 47619381)
214. Semenza, G. L. HIF-1: Upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev., 2009, 20(1), 51-56.
215. Denko, N. C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer, 2008, 8(9), 705-713.
216. Marin-Hernandez, A.; Gallardo-Perez, J. C.; Ralph, S. J.; Rodriguez-Enriquez, S.; Moreno-Sanchez, R. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev. Med. Chem., 2009, 9(9), 1084-1101.
217. Ozbudak, I. H.; Karaveli, S.; Simsek, T.; Erdogan, G.; Pestereli, E. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas. Gynecol. Oncol., 2008, 108(3), 603-608.
218. Iliopoulos, O.; Kibel, A.; Gray, S.; Kaelin, W. G., Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med., 1995, 1(8), 822-826.
219. Kim, J. W.; Gao, P.; Liu, Y. C.; Semenza, G. L.; Dang, C. V. Hypoxiainducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell. Biol., 2007, 27(21), 7381-7393. (Pubitemid 350033646)
220. Kim, J. W.; Tchernyshyov, I.; Semenza, G. L.; Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab., 2006, 3(3), 177-185.
221. Papandreou, I.; Cairns, R. A.; Fontana, L.; Lim, A. L.; Denko, N. C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab, 2006, 3(3), 187-197.
222. Semenza, G. L. HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J. Bioenerg. Biomembr., 2007, 39(3), 231-234. (Pubitemid 47619375)
223. Cockman, M. E.; Masson, N.; Mole, D. R.; Jaakkola, P.; Chang, G. W.; Clifford, S. C.; Maher, E. R.; Pugh, C. W.; Ratcliffe, P. J.; Maxwell, P. H. Hypoxia inducible factor-Alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem., 2000, 275(33), 25733-25741.
224. Maxwell, P. H.; Wiesener, M. S.; Chang, G. W.; Clifford, S. C.; Vaux, E. C.; Cockman, M. E.; Wykoff, C. C.; Pugh, C. W.; Maher, E. R.; Ratcliffe, P. J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 1999, 399(6733), 271-275. (Pubitemid 29246458)
225. Zhang, H.; Gao, P.; Fukuda, R.; Kumar, G.; Krishnamachary, B.; Zeller, K. I.; Dang, C. V.; Semenza, G. L. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of CMYC activity. Cancer Cell, 2007, 11(5), 407-420. (Pubitemid 46670080)
226. Samudio, I.; Fiegl, M.; Andreeff, M. Mitochondrial uncoupling and the Warburg effect: Molecular basis for the reprogramming of cancer cell metabolism. Cancer Res., 2009, 69(6), 2163-2166.
227. Samudio, I.; Fiegl, M.; McQueen, T.; Clise-Dwyer, K.; Andreeff, M. The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation. Cancer Res., 2008, 68(13), 5198-5205.
228. Mathupala, S. P.; Ko, Y. H.; Pedersen, P. L. The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies. Biochim. Biophys. Acta, 2010, 1797(6-7), 1225-1230.
229. Wilson, J. E. Isozymes of mammalian hexokinase: Structure, subcellular localization and metabolic function. J. Exp. Biol., 2003, 206(Pt 12), 2049-2057. (Pubitemid 36761808)
230. Bryson, J. M.; Coy, P. E.; Gottlob, K.; Hay, N.; Robey, R. B. Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J. Biol. Chem., 2002, 277(13), 11392-11400. (Pubitemid 34952906)
231. Gottlob, K.; Majewski, N.; Kennedy, S.; Kandel, E.; Robey, R. B.; Hay, N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev., 2001, 15(11), 1406-1418. (Pubitemid 32524647)
232. Rose, I. A.; O'Connell, E. L.; Litwin, S. Determination of the rate of hexokinase-glucose dissociation by the isotope-trapping method. J. Biol. Chem., 1974, 249(16), 5163-5168.
233. Fanciulli, M.; Paggi, M. G.; Bruno, T.; Del Carlo, C.; Bonetto, F.; Gentile, F. P.; Floridi, A. Glycolysis and growth rate in normal and in hexokinasetransfected NIH-3T3 cells. Oncol. Res., 1994, 6(9), 405-409.
234. Koren, I.; Raviv, Z.; Shoshan-Barmatz, V. Downregulation of voltagedependent anion channel-1 expression by RNA interference prevents cancer cell growth in vivo. Cancer Biol. Ther., 2010, 9(12), 1046-1052.
235. Shinohara, Y.; Ishida, T.; Hino, M.; Yamazaki, N.; Baba, Y.; Terada, H. Characterization of porin isoforms expressed in tumor cells. Eur. J. Biochem., 2000, 267(19), 6067-6073.
236. Simamura, E.; Hirai, K.; Shimada, H.; Koyama, J.; Niwa, Y.; Shimizu, S. Furanonaphthoquinones cause apoptosis of cancer cells by inducing the production of reactive oxygen species by the mitochondrial voltagedependent anion channel. Cancer Biol. Ther., 2006, 5(11), 1523-1529.
237. Simamura, E.; Shimada, H.; Ishigaki, Y.; Hatta, T.; Higashi, N.; Hirai, K. Bioreductive activation of quinone antitumor drugs by mitochondrial voltage-dependent anion channel 1. Anat. Sci. Int., 2008, 83(4), 261-266.
238. Grills, C.; Jithesh, P. V.; Blayney, J.; Zhang, S. D.; Fennell, D. A. Gene expression meta-Analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer. PLoS One, 2011, 6(1), e14635.
239. Li, M.; Xiao, Z. Q.; Chen, Z. C.; Li, J. L.; Li, C.; Zhang, P. F.; Li, M. Y. Proteomic analysis of the aging-related proteins in human normal colon epithelial tissue. J. Biochem. Mol. Biol., 2007, 40(1), 72-81. (Pubitemid 46182738)
240. Jiang, N.; Kham, S. K.; Koh, G. S.; Suang Lim, J. Y.; Ariffin, H.; Chew, F. T.; Yeoh, A. E. Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL). J. Proteomics, 2011, 74(6), 843-857.
241. Castagna, A.; Antonioli, P.; Astner, H.; Hamdan, M.; Righetti, S. C.; Perego, P.; Zunino, F.; Righetti, P. G. A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. Proteomics, 2004, 4(10), 3246-3267. (Pubitemid 39372405)
242. Voehringer, D. W.; Hirschberg, D. L.; Xiao, J.; Lu, Q.; Roederer, M.; Lock, C. B.; Herzenberg, L. A.; Steinman, L. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc. Natl. Acad. Sci. U. S. A., 2000, 97(6), 2680-2685. (Pubitemid 30159231)
243. Nawarak, J.; Huang-Liu, R.; Kao, S. H.; Liao, H. H.; Sinchaikul, S.; Chen, S. T.; Cheng, S. L. Proteomics analysis of A375 human malignant melanoma cells in response to arbutin treatment. Biochim. Biophys. Acta, 2009, 1794(2), 159-167.
244. Cheng, S. L.; Liu, R. H.; Sheu, J. N.; Chen, S. T.; Sinchaikul, S.; Tsay, G. J. Toxicogenomics of A375 human malignant melanoma cells treated with arbutin. J. Biomed. Sci., 2007, 14(1), 87-105. (Pubitemid 46295276)
245. Takagi-Morishita, Y.; Yamada, N.; Sugihara, A.; Iwasaki, T.; Tsujimura, T.; Terada, N. Mouse uterine epithelial apoptosis is associated with expression of mitochondrial voltage-dependent anion channels, release of cytochrome C from mitochondria, and the ratio of Bax to Bcl-2 or Bcl-X. Biol. Reprod., 2003, 68(4), 1178-1184. (Pubitemid 36359105)
246. Lu, A. J.; Dong, C. W.; Du, C. S.; Zhang, Q. Y. Characterization and expression analysis of Paralichthys olivaceus voltage-dependent anion channel (VDAC) gene in response to virus infection. Fish Shellfish Immunol., 2007, 23(3), 601-613.
247. Godbole, A.; Varghese, J.; Sarin, A.; Mathew, M. K. VDAC is a conserved element of death pathways in plant and animal systems. Biochim. Biophys. Acta, 2003, 1642(1-2), 87-96. (Pubitemid 37338282)
248. Ghosh, T.; Pandey, N.; Maitra, A.; Brahmachari, S. K.; Pillai, B. A role for voltage-dependent anion channel Vdac1 in polyglutamine-mediated neuronal cell death. PLoS One, 2007, 2(11), e1170.
249. De Pinto, V.; Tomasello, F.; Messina, A.; Guarino, F.; Benz, R.; La Mendola, D.; Magri, A.; Milardi, D.; Pappalardo, G. Determination of the conformation of the human VDAC1 N-terminal peptide, a protein moiety essential for the functional properties of the pore. ChemBioChem., 2007, 8(7), 744-756. (Pubitemid 47183631)
250. Tomasello, F.; Messina, A.; Lartigue, L.; Schembri, L.; Medina, C.; Reina, S.; Thoraval, D.; Crouzet, M.; Ichas, F.; De Pinto, V.; De Giorgi, F. Outer membrane VDAC1 controls permeability transition of the inner mitochondrial membrane in cellulo during stress-induced apoptosis. Cell Res., 2009, 19(12), 1363-1376.
251. Adams, V.; Griffin, L.; Towbin, J.; Gelb, B.; Worley, K.; McCabe, E. R. Porin interaction with hexokinase and glycerol kinase: Metabolic microcompartmentation at the outer mitochondrial membrane. Biochem. Med. Metab. Biol., 1991, 45(3), 271-291.
252. Goldin, N.; Arzoine, L.; Heyfets, A.; Israelson, A.; Zaslavsky, Z.; Bravman, T.; Bronner, V.; Notcovich, A.; Shoshan-Barmatz, V.; Flescher, E. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase. Oncogene, 2008, 27(34), 4636-4643.
253. Schlattner, U.; Dolder, M.; Wallimann, T.; Tokarska-Schlattner, M. Mitochondrial creatine kinase and mitochondrial outer membrane porin show a direct interaction that is modulated by calcium. J. Biol. Chem., 2001, 276(51), 48027-48030.
254. Le Mellay, V.; Troppmair, J.; Benz, R.; Rapp, U. R. Negative regulation of mitochondrial VDAC channels by C-Raf kinase. BMC Cell Biol., 2002, 3, 14.
255. Vyssokikh, M. Y.; Brdiczka, D. The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta Biochim. Pol., 2003, 50(2), 389-404. (Pubitemid 37034693)
256. Veenman, L.; Papadopoulos, V.; Gavish, M. Channel-like functions of the 18-kDa translocator protein (TSPO): Regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr. Pharm. Des., 2007, 13(23), 2385-2405. (Pubitemid 47321571)
257. Rostovtseva, T. K.; Sheldon, K. L.; Hassanzadeh, E.; Monge, C.; Saks, V.; Bezrukov, S. M.; Sackett, D. L. Tubulin binding blocks mitochondrial voltage-dependent anion channel and regulates respiration. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(48), 18746-18751.
258. Xu, X.; Forbes, J. G.; Colombini, M. Actin modulates the gating of Neurospora crassa VDAC. J. Membr. Biol., 2001, 180(1), 73-81. (Pubitemid 32207610)
259. Kusano, H.; Shimizu, S.; Koya, R. C.; Fujita, H.; Kamada, S.; Kuzumaki, N.; Tsujimoto, Y. Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene, 2000, 19(42), 4807-4814.
260. Adams, J. M.; Cory, S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene, 2007, 26(9), 1324-1337. (Pubitemid 46328466)
261. Llambi, F.; Green, D. R. Apoptosis and oncogenesis: Give and take in the BCL-2 family. Curr. Opin. Genet. Dev., 2011, 21(1), 12-20.
262. Tsujimoto, Y.; Shimizu, S. The voltage-dependent anion channel: An essential player in apoptosis. Biochimie, 2002, 84(2-3), 187-193.
263. Xie, G. C.; Wilson, J. E. Rat brain hexokinase: The hydrophobic N-terminus of the mitochondrially bound enzyme is inserted in the lipid bilayer. Arch. Biochem. Biophys., 1988, 267(2), 803-810. (Pubitemid 19020367)
264. Hashimoto, M.; Wilson, J. E. Membrane potential-dependent conformational changes in mitochondrially bound hexokinase of brain. Arch. Biochem. Biophys., 2000, 384(1), 163-173.
265. Sun, L.; Shukair, S.; Naik, T. J.; Moazed, F.; Ardehali, H. Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol. Cell. Biol., 2008, 28(3), 1007-1017. (Pubitemid 351160057)
266. Bustamante, E.; Pedersen, P. L. Mitochondrial hexokinase of rat hepatoma cells in culture: Solubilization and kinetic properties. Biochemistry (Mosc). 1980, 19(22), 4972-4977. (Pubitemid 11205877)
267. Baijal, M.; Wilson, J. E. Residues putatively involved in binding of ATP and glucose 6-phosphate to a mammalian hexokinase: Site-directed mutation at analogous positions in the N-And C-terminal halves of the type I isozyme. Arch. Biochem. Biophys., 1995, 321(2), 413-420.
268. Wilson, J. E.; Chung, V. Rat brain hexokinase: Further studies on the specificity of the hexose and hexose 6-phosphate binding sites. Arch. Biochem. Biophys., 1989, 269(2), 517-525. (Pubitemid 19075760)
269. da-Silva, W. S.; Gomez-Puyou, A.; de Gomez-Puyou, M. T.; Moreno-Sanchez, R.; De Felice, F. G.; de Meis, L.; Oliveira, M. F.; Galina, A. Mitochondrial bound hexokinase activity as a preventive antioxidant defense: Steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. J. Biol. Chem., 2004, 279(38), 39846-39855. (Pubitemid 39258256)
270. Ahmad, A.; Ahmad, S.; Schneider, B. K.; Allen, C. B.; Chang, L. Y.; White, C. W. Elevated expression of hexokinase II protects human lung epitheliallike A549 cells against oxidative injury. Am. J. Physiol. Lung Cell Mol. Physiol., 2002, 283(3), L573-584.
271. Majewski, N.; Nogueira, V.; Robey, R. B.; Hay, N. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol. Cell. Biol., 2004, 24(2), 730-740. (Pubitemid 38057924)
272. Shulga, N.; Wilson-Smith, R.; Pastorino, J. G. Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism. Cell Cycle, 2009, 8(20), 3355-3364.
273. Robey, R. B.; Hay, N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene, 2006, 25(34), 4683-4696. (Pubitemid 44187618)
274. Gelb, B. D.; Adams, V.; Jones, S. N.; Griffin, L. D.; MacGregor, G. R.; McCabe, E. R. Targeting of hexokinase 1 to liver and hepatoma mitochondria. Proc. Natl. Acad. Sci. U. S. A., 1992, 89(1), 202-206.
275. Penso, J.; Beitner, R. Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells. Eur. J. Pharmacol., 1998, 342(1), 113-117. (Pubitemid 28131352)
276. Majewski, N.; Nogueira, V.; Bhaskar, P.; Coy, P. E.; Skeen, J. E.; Gottlob, K.; Chandel, N. S.; Thompson, C. B.; Robey, R. B.; Hay, N. Hexokinasemitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell, 2004, 16(5), 819-830. (Pubitemid 39586539)
277. Pereira da Silva, A. P.; El-Bacha, T.; Kyaw, N.; dos Santos, R. S.; da-Silva, W. S.; Almeida, F. C.; Da Poian, A. T.; Galina, A. Inhibition of energyproducing pathways of HepG2 cells by 3-bromopyruvate. Biochem. J., 2009, 417(3), 717-726.
278. Ko, Y. H.; Pedersen, P. L.; Geschwind, J. F. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: Characterization and targeting hexokinase. Cancer Lett., 2001, 173(1), 83-91. (Pubitemid 32907513)
279. Geschwind, J. F.; Ko, Y. H.; Torbenson, M. S.; Magee, C.; Pedersen, P. L. Novel therapy for liver cancer: Direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res., 2002, 62(14), 3909-3913. (Pubitemid 34791050)
280. Ko, Y. H.; Smith, B. L.; Wang, Y.; Pomper, M. G.; Rini, D. A.; Torbenson, M. S.; Hullihen, J.; Pedersen, P. L. Advanced cancers: Eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem. Biophys. Res. Commun., 2004, 324(1), 269-275. (Pubitemid 39311489)
281. Letai, A.; Sorcinelli, M. D.; Beard, C.; Korsmeyer, S. J. Antiapoptotic BCL-2 is required for maintenance of a model leukemia. Cancer Cell, 2004, 6(3), 241-249. (Pubitemid 39222037)
282. Certo, M.; Del Gaizo Moore, V.; Nishino, M.; Wei, G.; Korsmeyer, S.; Armstrong, S. A.; Letai, A. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell, 2006, 9(5), 351-365. (Pubitemid 43668734)
283. Sentman, C. L.; Shutter, J. R.; Hockenbery, D.; Kanagawa, O.; Korsmeyer, S. J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 1991, 67(5), 879-888. (Pubitemid 121001502)
284. Miyashita, T.; Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 1993, 81(1), 151-157. (Pubitemid 23013689)
285. Danial, N. N. BCL-2 family proteins: Critical checkpoints of apoptotic cell death. Clin. Cancer Res., 2007, 13(24), 7254-7263.
286. Gross, A.; McDonnell, J. M.; Korsmeyer, S. J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev., 1999, 13(15), 1899-1911. (Pubitemid 29407357)
287. Danial, N. N.; Korsmeyer, S. J. Cell death: Critical control points. Cell, 2004, 116(2), 205-219. (Pubitemid 38167313)
288. Huang, D. C.; Strasser, A. BH3-Only proteins-essential initiators of apoptotic cell death. Cell, 2000, 103(6), 839-842.
289. Breckenridge, D. G.; Xue, D. Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr. Opin. Cell Biol., 2004, 16(6), 647-652. (Pubitemid 39463115)
290. Krajewski, S.; Tanaka, S.; Takayama, S.; Schibler, M. J.; Fenton, W.; Reed, J. C. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res., 1993, 53(19), 4701-4714. (Pubitemid 23304404)
291. Gross, A.; Jockel, J.; Wei, M. C.; Korsmeyer, S. J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J., 1998, 17(14), 3878-3885. (Pubitemid 28333974)
292. Oancea, M.; Mani, A.; Hussein, M. A.; Almasan, A. Apoptosis of multiple myeloma. Int. J. Hematol., 2004, 80(3), 224-231. (Pubitemid 39410928)
293. Tsujimoto, Y.; Finger, L. R.; Yunis, J.; Nowell, P. C.; Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science, 1984, 226(4678), 1097-1099. (Pubitemid 15217831)
294. Bakhshi, A.; Jensen, J. P.; Goldman, P.; Wright, J. J.; McBride, O. W.; Epstein, A. L.; Korsmeyer, S. J. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell, 1985, 41(3), 899-906. (Pubitemid 15243395)
295. Iqbal, J.; Neppalli, V. T.; Wright, G.; Dave, B. J.; Horsman, D. E.; Rosenwald, A.; Lynch, J.; Hans, C. P.; Weisenburger, D. D.; Greiner, T. C.; Gascoyne, R. D.; Campo, E.; Ott, G.; Muller-Hermelink, H. K.; Delabie, J.; Jaffe, E. S.; Grogan, T. M.; Connors, J. M.; Vose, J. M.; Armitage, J. O.; Staudt, L. M.; Chan, W. C. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J. Clin. Oncol., 2006, 24(6), 961-968. (Pubitemid 46638851)
296. Scorrano, L.; Oakes, S. A.; Opferman, J. T.; Cheng, E. H.; Sorcinelli, M. D.; Pozzan, T.; Korsmeyer, S. J. BAX and BAK regulation of endoplasmic reticulum Ca2+: A control point for apoptosis. Science, 2003, 300(5616), 135-139. (Pubitemid 36423046)
297. De Marchi, U.; Campello, S.; Szabo, I.; Tombola, F.; Martinou, J. C.; Zoratti, M. Bax does not directly participate in the Ca(2+)-induced permeability transition of isolated mitochondria. J. Biol. Chem., 2004, 279(36), 37415-37422. (Pubitemid 39195450)
298. Shi, Y.; Jiang, C.; Chen, Q.; Tang, H. One-step on-column affinity refolding purification and functional analysis of recombinant human VDAC1. Biochem. Biophys. Res. Commun., 2003, 303(2), 475-482. (Pubitemid 36349194)
299. Scharstuhl, A.; Mutsaers, H. A.; Pennings, S. W.; Russel, F. G.; Wagener, F. A. Involvement of VDAC, Bax and ceramides in the efflux of AIF from mitochondria during curcumin-induced apoptosis. PLoS One, 2009, 4(8), e6688.
300. Yamagata, H.; Shimizu, S.; Nishida, Y.; Watanabe, Y.; Craigen, W. J.; Tsujimoto, Y. Requirement of voltage-dependent anion channel 2 for proapoptotic activity of Bax. Oncogene, 2009, 28(40), 3563-3572.
301. Shimizu, S.; Matsuoka, Y.; Shinohara, Y.; Yoneda, Y.; Tsujimoto, Y. Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J. Cell Biol., 2001, 152(2), 237-250. (Pubitemid 34285595)
302. Rostovtseva, T. K.; Antonsson, B.; Suzuki, M.; Youle, R. J.; Colombini, M.; Bezrukov, S. M. Bid, but not Bax, regulates VDAC channels. J. Biol. Chem., 2004, 279(14), 13575-13583. (Pubitemid 38468883)
303. Pradelli, L. A.; Beneteau, M.; Ricci, J. E. Mitochondrial control of caspasedependent and -independent cell death. Cell. Mol. Life Sci., 2010, 67(10), 1589-1597.
304. Levin, E.; Premkumar, A.; Veenman, L.; Kugler, W.; Leschiner, S.; Spanier, I.; Weisinger, G.; Lakomek, M.; Weizman, A.; Snyder, S. H.; Pasternak, G. W.; Gavish, M. The peripheral-type benzodiazepine receptor and tumorigenicity: Isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line. Biochemistry (Mosc). 2005, 44(29), 9924-9935. (Pubitemid 41033459)
305. Papadopoulos, V.; Baraldi, M.; Guilarte, T. R.; Knudsen, T. B.; Lacapere, J. J.; Lindemann, P.; Norenberg, M. D.; Nutt, D.; Weizman, A.; Zhang, M. R.; Gavish, M. Translocator protein (18kDa): New nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci., 2006, 27(8), 402-409. (Pubitemid 44069585)
306. Zheng, J.; Boisgard, R.; Siquier-Pernet, K.; Decaudin, D.; Dolle, F.; Tavitian, B. Differential Expression of the 18 kDa Translocator Protein (TSPO) by Neoplastic and Inflammatory Cells in Mouse Tumors of Breast Cancer. Mol. Pharm., 2011, 8(3), 823-832.
307. Batarseh, A.; Papadopoulos, V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol. Cell. Endocrinol., 2010, 327(1-2), 1-12.
308. Hardwick, M.; Fertikh, D.; Culty, M.; Li, H.; Vidic, B.; Papadopoulos, V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: Correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res., 1999, 59(4), 831-842. (Pubitemid 29086736)
309. Azarashvili, T.; Stricker, R.; Reiser, G. The mitochondria permeability transition pore complex in the brain with interacting proteins -promising targets for protection in neurodegenerative diseases. Biol. Chem., 2010, 391(6), 619-629.
310. Krestinina, O. V.; Grachev, D. E.; Odinokova, I. V.; Reiser, G.; Evtodienko, Y. V.; Azarashvili, T. S. Effect of peripheral benzodiazepine receptor (PBR/TSPO) ligands on opening of Ca2+-induced pore and phosphorylation of 3.5-kDa polypeptide in rat brain mitochondria. Biochemistry (Mosc). 2009, 74(4), 421-429.
311. McEnery, M. W.; Snowman, A. M.; Trifiletti, R. R.; Snyder, S. H. Isolation of the mitochondrial benzodiazepine receptor: Association with the voltagedependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. U. S. A., 1992, 89(8), 3170-3174.
312. Santidrian, A. F.; Cosialls, A. M.; Coll-Mulet, L.; Iglesias-Serret, D.; de Frias, M.; Gonzalez-Girones, D. M.; Campas, C.; Domingo, A.; Pons, G.; Gil, J. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells. Haematologica, 2007, 92(12), 1631-1638. (Pubitemid 350248242)
313. Gavish, M.; Bachman, I.; Shoukrun, R.; Katz, Y.; Veenman, L.; Weisinger, G.; Weizman, A. Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev., 1999, 51(4), 629-650.
314. Veenman, L.; Shandalov, Y.; Gavish, M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J. Bioenerg. Biomembr., 2008, 40(3), 199-205.
315. Veenman, L.; Leschiner, S.; Spanier, I.; Weisinger, G.; Weizman, A.; Gavish, M. PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain. J. Neurochem., 2002, 80(5), 917-927. (Pubitemid 34809245)
316. Dessi, S.; Batetta, B.; Anchisi, C.; Pani, P.; Costelli, P.; Tessitore, L.; Baccino, F. M. Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br. J. Cancer, 1992, 66(5), 787-793.
317. Dessi, S.; Batetta, B.; Pulisci, D.; Spano, O.; Anchisi, C.; Tessitore, L.; Costelli, P.; Baccino, F. M.; Aroasio, E.; Pani, P. Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer, 1994, 73(2), 253-258. (Pubitemid 24030598)
318. Kolanjiappan, K.; Ramachandran, C. R.; Manoharan, S. Biochemical changes in tumor tissues of oral cancer patients. Clin. Biochem., 2003, 36(1), 61-65. (Pubitemid 36126392)
319. Rudling, M.; Collins, V. P. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels are coordinately reduced in human renal cell carcinoma. Biochim. Biophys. Acta, 1996, 1299(1), 75-79. (Pubitemid 26007735)
320. Yoshioka, Y.; Sasaki, J.; Yamamoto, M.; Saitoh, K.; Nakaya, S.; Kubokawa, M. Quantitation by (1)H-NMR of dolichol, cholesterol and cholinecontaining lipids in extracts of normal and phathological thyroid tissue. NMR Biomed., 2000, 13(7), 377-383. (Pubitemid 32001046)
321. Veenman, L.; Gavish, M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol. Ther., 2006, 110(3), 503-524.
322. Bernier-Valentin, F.; Rousset, B. Interaction of tubulin with rat liver mitochondria. J. Biol. Chem., 1982, 257(12), 7092-7099. (Pubitemid 12022296)
323. Carre, M.; Andre, N.; Carles, G.; Borghi, H.; Brichese, L.; Briand, C.; Braguer, D. Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J. Biol. Chem., 2002, 277(37), 33664-33669.
324. Rostovtseva, T. K.; Petrache, H. I.; Kazemi, N.; Hassanzadeh, E.; Bezrukov, S. M. Interfacial polar interactions affect gramicidin channel kinetics. Biophys. J., 2008, 94(4), L23-25.
325. Priel, A.; Tuszynski, J. A.; Woolf, N. J. Transitions in microtubule C-termini conformations as a possible dendritic signaling phenomenon. Eur. Biophys. J., 2005, 35(1), 40-52. (Pubitemid 41667024)
326. Sackett, D. L.; Bhattacharyya, B.; Wolff, J. Tubulin subunit carboxyl termini determine polymerization efficiency. J. Biol. Chem., 1985, 260(1), 43-45. (Pubitemid 15165276)
327. Rostovtseva, T. K.; Bezrukov, S. M. VDAC regulation: Role of cytosolic proteins and mitochondrial lipids. J. Bioenerg. Biomembr., 2008, 40(3), 163-170.
328. Timohhina, N.; Guzun, R.; Tepp, K.; Monge, C.; Varikmaa, M.; Vija, H.; Sikk, P.; Kaambre, T.; Sackett, D.; Saks, V. Direct measurement of energy fluxes from mitochondria into cytoplasm in permeabilized cardiac cells in situ: Some evidence for Mitochondrial Interactosome. J. Bioenerg. Biomembr., 2009, 41(3), 259-275.
329. Maldonado, E. N.; Patnaik, J.; Mullins, M. R.; Lemasters, J. J. Free tubulin modulates mitochondrial membrane potential in cancer cells. Cancer Res., 2010, 70(24), 10192-10201.
330. Roman, I.; Figys, J.; Steurs, G.; Zizi, M. Direct measurement of VDAC-Actin interaction by surface plasmon resonance. Biochim. Biophys. Acta, 2006, 1758(4), 479-486. (Pubitemid 43767729)
331. Kwiatkowski, D. J. Functions of gelsolin: Motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol., 1999, 11(1), 103-108.
332. Silacci, P.; Mazzolai, L.; Gauci, C.; Stergiopulos, N.; Yin, H. L.; Hayoz, D. Gelsolin superfamily proteins: Key regulators of cellular functions. Cell. Mol. Life Sci., 2004, 61(19-20), 2614-2623. (Pubitemid 39586521)
333. Sun, H. Q.; Yamamoto, M.; Mejillano, M.; Yin, H. L. Gelsolin, a multifunctional actin regulatory protein. J. Biol. Chem., 1999, 274(47), 33179-33182. (Pubitemid 129511609)
334. Kothakota, S.; Azuma, T.; Reinhard, C.; Klippel, A.; Tang, J.; Chu, K.; McGarry, T. J.; Kirschner, M. W.; Koths, K.; Kwiatkowski, D. J.; Williams, L. T. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science, 1997, 278(5336), 294-298. (Pubitemid 27450877)
335. Azuma, T.; Koths, K.; Flanagan, L.; Kwiatkowski, D. Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression. J. Biol. Chem., 2000, 275(6), 3761-3766. (Pubitemid 30094596)
336. Koya, R. C.; Fujita, H.; Shimizu, S.; Ohtsu, M.; Takimoto, M.; Tsujimoto, Y.; Kuzumaki, N. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J. Biol. Chem., 2000, 275(20), 15343-15349. (Pubitemid 30337262)
337. Linden, M.; Karlsson, G. Identification of porin as a binding site for MAP2. Biochem. Biophys. Res. Commun., 1996, 218(3), 833-836. (Pubitemid 26050749)
338. Schwarzer, C.; Barnikol-Watanabe, S.; Thinnes, F. P.; Hilschmann, N. Voltage-dependent anion-selective channel (VDAC) interacts with the dynein light chain Tctex1 and the heat-shock protein PBP74. Int. J. Biochem. Cell Biol., 2002, 34(9), 1059-1070. (Pubitemid 34493767)
339. Wagner, O. I.; Lifshitz, J.; Janmey, P. A.; Linden, M.; McIntosh, T. K.; Leterrier, J. F. Mechanisms of mitochondria-neurofilament interactions. J. Neurosci., 2003, 23(27), 9046-9058. (Pubitemid 37243805)
340. Granville, D. J.; Gottlieb, R. A. The mitochondrial voltage-dependent anion channel (VDAC) as a therapeutic target for initiating cell death. Curr. Med. Chem., 2003, 10(16), 1527-1533. (Pubitemid 36896554)
341. Yagoda, N.; von Rechenberg, M.; Zaganjor, E.; Bauer, A. J.; Yang, W. S.; Fridman, D. J.; Wolpaw, A. J.; Smukste, I.; Peltier, J. M.; Boniface, J. J.; Smith, R.; Lessnick, S. L.; Sahasrabudhe, S.; Stockwell, B. R. RAS-RAFMEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature, 2007, 447(7146), 864-868. (Pubitemid 46920135)
342. Yang, W. S.; Stockwell, B. R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol., 2008, 15(3), 234-245. (Pubitemid 351391983)
343. Sahasrabudhe, S. R.; Lai, S.; Pierce, M.; Clemens, C.; Venkat, R.; Rebentisch, M.; Senina, A.; Becklin, R.; Richards, S. K.; Erkkila, T.; Robbins, P. B. In: Selective in vitro and in vivo anti-tumor activity of PRLX 93936 in biological models of melanoma and ovarian cancer., American Society of Clinical Oncology, Journal of Clinical Oncology, 2008.
344. Advani, P. P.; Paulus, A.; Masood, A.; Sher, T.; Chanan-Khan, A. Pharmacokinetic evaluation of oblimersen sodium for the treatment of chronic lymphocytic leukemia. Expert Opin. Drug Metab. Toxicol., 2011, 7(6), 765-774.
345. Pro, B.; Leber, B.; Smith, M.; Fayad, L.; Romaguera, J.; Hagemeister, F.; Rodriguez, A.; McLaughlin, P.; Samaniego, F.; Zwiebel, J.; Lopez, A.; Kwak, L.; Younes, A. Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma. Br. J. Haematol., 2008, 143(3), 355-360.
346. Rom, J.; von Minckwitz, G.; Marme, F.; Ataseven, B.; Kozian, D.; Sievert, M.; Schlehe, B.; Schuetz, F.; Scharf, A.; Kaufmann, M.; Sohn, C.; Schneeweiss, A. Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancer. Ann. Oncol., 2009, 20(11), 1829-1835.
347. Tan, W.; Loke, Y. H.; Stein, C. A.; Miller, P.; Colombini, M. Phosphorothioate oligonucleotides block the VDAC channel. Biophys. J., 2007, 93(4), 1184-1191. (Pubitemid 47330898)
348. Haridas, V.; Kim, S. O.; Nishimura, G.; Hausladen, A.; Stamler, J. S.; Gutterman, J. U. Avicinylation (thioesterification): A protein modification that can regulate the response to oxidative and nitrosative stress. Proc. Natl. Acad. Sci. U. S. A., 2005, 102(29), 10088-10093. (Pubitemid 41023330)
349. Gaikwad, A.; Poblenz, A.; Haridas, V.; Zhang, C.; Duvic, M.; Gutterman, J. Triterpenoid electrophiles (avicins) suppress heat shock protein-70 and xlinked inhibitor of apoptosis proteins in malignant cells by activation of ubiquitin machinery: Implications for proapoptotic activity. Clin. Cancer Res., 2005, 11(5), 1953-1962. (Pubitemid 40471861)
350. Gutterman, J. U.; Lai, H. T.; Yang, P.; Haridas, V.; Gaikwad, A.; Marcus, S. Effects of the tumor inhibitory triterpenoid avicin G on cell integrity, cytokinesis, and protein ubiquitination in fission yeast. Proc. Natl. Acad. Sci. U. S. A., 2005, 102(36), 12771-12776. (Pubitemid 41279441)
351. Haridas, V.; Li, X.; Mizumachi, T.; Higuchi, M.; Lemeshko, V. V.; Colombini, M.; Gutterman, J. U. Avicins, a novel plant-derived metabolite lowers energy metabolism in tumor cells by targeting the outer mitochondrial membrane. Mitochondrion, 2007, 7(3), 234-240. (Pubitemid 46395201)
352. Lemeshko, V. V.; Haridas, V.; Quijano Perez, J. C.; Gutterman, J. U. Avicins, natural anticancer saponins, permeabilize mitochondrial membranes. Arch. Biochem. Biophys., 2006, 454(2), 114-122. (Pubitemid 44547869)
353. Wong, D. T.; Bymaster, F. P.; Engleman, E. A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci., 1995, 57(5), 411-441.
354. Fuller, R. W.; Wong, D. T.; Robertson, D. W. Fluoxetine, a selective inhibitor of serotonin uptake. Med. Res. Rev., 1991, 11(1), 17-34.
355. Frick, L. R.; Rapanelli, M.; Arcos, M. L.; Cremaschi, G. A.; Genaro, A. M. Oral administration of fluoxetine alters the proliferation/apoptosis balance of lymphoma cells and up-regulates T cell immunity in tumor-bearing mice. Eur. J. Pharmacol., 2011, 659(2-3), 265-272.
356. Cloonan, S. M.; Drozgowska, A.; Fayne, D.; Williams, D. C. The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters. Leuk. Lymphoma, 2010, 51(3), 523-539.
357. Lee, C. S.; Kim, Y. J.; Jang, E. R.; Kim, W.; Myung, S. C. Fluoxetine induces apoptosis in ovarian carcinoma cell line OVCAR-3 through reactive oxygen species-dependent activation of nuclear factor-kappaB. Basic Clin. Pharmacol. Toxicol., 2010, 106(6), 446-453.
358. Wright, S. C.; Zhong, J.; Larrick, J. W. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J., 1994, 8(9), 654-660. (Pubitemid 24198683)
359. Lee, H. J.; Kim, J. W.; Yim, S. V.; Kim, M. J.; Kim, S. A.; Kim, Y. J.; Kim, C. J.; Chung, J. H. Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats. Mol. Psychiatry, 2001, 6(6), 725-728. (Pubitemid 33020593)
360. Chiou, S. H.; Chen, S. J.; Peng, C. H.; Chang, Y. L.; Ku, H. H.; Hsu, W. M.; Ho, L. L.; Lee, C. H. Fluoxetine up-regulates expression of cellular FLICEinhibitory protein and inhibits LPS-induced apoptosis in hippocampusderived neural stem cell. Biochem. Biophys. Res. Commun., 2006, 343(2), 391-400.
361. Wang, Y.; Zhang, X. H.; Wang, H. L. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats. Can. J. Physiol. Pharmacol., 2011, 89(5), 345-354.
362. Peer, D.; Dekel, Y.; Melikhov, D.; Margalit, R. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models. Cancer Res., 2004, 64(20), 7562-7569. (Pubitemid 39372101)
363. Argov, M.; Kashi, R.; Peer, D.; Margalit, R. Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen. Cancer Lett., 2009, 274(1), 118-125.
364. Ong, J. C.; Sun, F.; Chan, E. Development of stealth liposome coencapsulating doxorubicin and fluoxetine. J. Liposome Res., 2011.
365. Nahon, E.; Israelson, A.; Abu-Hamad, S.; Varda, S. B. Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death. FEBS Lett., 2005, 579(22), 5105-5110. (Pubitemid 41242861)
366. Thinnes, F. P. Does fluoxetine (Prozak) block mitochondrial permeability transition by blocking VDAC as part of permeability transition pores? Mol. Genet. Metab., 2005, 84(4), 378. (Pubitemid 40386889)
367. Santin, G.; Piccolini, V. M.; Veneroni, P.; Barni, S.; Bernocchi, G.; Bottone, M. G. Different patterns of apoptosis in response to cisplatin in B50 neuroblastoma rat cells. Histol. Histopathol., 2011, 26(7), 831-842.
368. Zamarin, D.; Garcia-Sastre, A.; Xiao, X.; Wang, R.; Palese, P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog., 2005, 1(1), e4.
369. Cullen, K. J.; Yang, Z.; Schumaker, L.; Guo, Z. Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer. J. Bioenerg. Biomembr., 2007, 39(1), 43-50. (Pubitemid 46877172)
370. Yang, Z.; Schumaker, L. M.; Egorin, M. J.; Zuhowski, E. G.; Guo, Z.; Cullen, K. J. Cisplatin preferentially binds mitochondrial DNA and voltagedependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: Possible role in apoptosis. Clin. Cancer Res., 2006, 12(19), 5817-5825. (Pubitemid 44629614)
371. Thinnes, F. P. Human type-1 VDAC, a cisplatin target involved in either apoptotic pathway. Mol. Genet. Metab., 2009, 97(2), 163.
372. Adams, J. D., Jr.; Klaidman, L. K. Acrolein-induced oxygen radical formation. Free Radic. Biol. Med., 1993, 15(2), 187-193. (Pubitemid 23218821)
373. Voulgaridou, G. P.; Anestopoulos, I.; Franco, R.; Panayiotidis, M. I.; Pappa, A. DNA damage induced by endogenous aldehydes: Current state of knowledge. Mutat. Res., 2011, 711(1-2), 13-27.
374. Izard, C.; Libermann, C. Acrolein. Mutat. Res., 1978, 47(2), 115-138. (Pubitemid 8256892)
375. Takano, K.; Ogura, M.; Yoneda, Y.; Nakamura, Y. Oxidative metabolites are involved in polyamine-induced microglial cell death. Neuroscience, 2005, 134(4), 1123-1131. (Pubitemid 41207365)
376. Luo, J.; Uchida, K.; Shi, R. Accumulation of acrolein-protein adducts after traumatic spinal cord injury. Neurochem. Res., 2005, 30(3), 291-295. (Pubitemid 40880804)
377. Nam, D. T.; Arseneault, M.; Murthy, V.; Ramassamy, C. Potential role of acrolein in neurodegeneration and in Alzheimer's disease. Curr. Mol. Pharmacol., 2010, 3(2), 66-78.
378. Mello, C. F.; Sultana, R.; Piroddi, M.; Cai, J.; Pierce, W. M.; Klein, J. B.; Butterfield, D. A. Acrolein induces selective protein carbonylation in synaptosomes. Neuroscience, 2007, 147(3), 674-679. (Pubitemid 46990643)
379. Folkman, J. Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp. Cell Res., 2006, 312(5), 594-607. (Pubitemid 43290336)
380. Karamouzis, M. V.; Moschos, S. J. The use of endostatin in the treatment of solid tumors. Expert Opin. Biol. Ther., 2009, 9(5), 641-648.
381. Yuan, S.; Fu, Y.; Wang, X.; Shi, H.; Huang, Y.; Song, X.; Li, L.; Song, N.; Luo, Y. Voltage-dependent anion channel 1 is involved in endostatininduced endothelial cell apoptosis. FASEB J., 2008, 22(8), 2809-2820.
382. Renvoize, C.; Biola, A.; Pallardy, M.; Breard, J. Apoptosis: Identification of dying cells. Cell Biol. Toxicol., 1998, 14(2), 111-120. (Pubitemid 28123601)